CGIM
INSM icon

Cannon Global Investment Management’s Insmed INSM Stock Holding History

Cannon Global Investment Management’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-4,500
Closed -$648K – 83
2025
Q3 		$648K Buy
+4,500
New +$551K 0.97% 30

Other funds holding INSM

JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Cannon Global Investment Management's INSM Position: Q4 2025 in Review

Cannon Global Investment Management sold out of Insmed (INSM) in Q4 2025, closing a stake of 4,500 shares — an estimated $648K sold.

Cannon Global Investment Management first reported a position in INSM in Q3 2025 and held it in 1 quarter. The position peaked at $648K in Q3 2025. 678 funds tracked by Wall St. Rank hold INSM as of Q4 2025.

  • Cannon Global Investment Management reported no remaining Insmed position as of Q4 2025 after selling out during the quarter.
  • Cannon Global Investment Management sold 4,500 Insmed shares in Q4 2025, an estimated $648K.
  • Cannon Global Investment Management first reported a position in Insmed in Q3 2025 and held it in 1 quarter.
  • Cannon Global Investment Management's Insmed position peaked at $648K in Q3 2025.
  • 678 funds tracked by Wall St. Rank held Insmed as of Q4 2025.

Based on Cannon Global Investment Management's 13F filing for Q4 2025, filed 27 Jan 2026.